Clofazimine should be used in all cases of leprosy, says Indian research council

Clofazimine should be added to the regimen of drugs used to treat paucibacillary leprosy, the Indian Council of Medical Research has recommended.1

Clofazimine is a lipophilic riminophenazine antibiotic with antibacterial and anti-inflammatory properties. The latest recommendation from the Indian Council of Medical Research is based on a review it conducted on published data that showed that clofazimine “can be safely used . . . along with dapsone and rifampicin for the 6 month multidrug therapy (MDT) being used in the treatment of paucibacillary leprosy.”

 

Read the full article by Dr. Soumyadeep B at the British Medical Journal (Click)

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s